Genito-urinary tract infections are among the most frequent reasons patients present to healthcare facilities in Nigeria. These infections span from simple bladder inflammation to severe kidney infections and sexually transmitted conditions. Understanding the microbial culprits guides rational drug therapy.
Antibiotics used in genito-urinary disorders belong to several pharmacological classes, each disrupting bacterial survival differently.
Uncomplicated urinary tract infections, such as acute cystitis in non-pregnant women, require prompt empirical treatment to relieve symptoms and prevent upper tract involvement. First-line agents must balance efficacy with minimal collateral damage to normal flora.
Nitrofurantoin macrocrystals taken for five days are a preferred choice due to low resistance rates. Alternatively, a single three-gram dose of fosfomycin trometamol offers a convenient single-day regimen. Trimethoprim-sulfamethoxazole is traditionally used, but local resistance data must guide its selection. Fluoroquinolones, while highly effective, are generally reserved for complicated cases or alternative scenarios due to concerns over rising resistance and adverse effects.
Pyelonephritis and complicated urinary infections—occurring in pregnancy, males, or patients with structural urinary tract abnormalities—demand aggressive, broader-spectrum antimicrobial therapy and often hospitalization.
Initial management frequently starts with parenteral regimens such as intravenous ceftriaxone or fluoroquinolones like ciprofloxacin, depending on local sensitivity patterns. Treatment duration extends significantly beyond simple cystitis, usually lasting seven to fourteen days to ensure complete eradication from renal parenchyma. Urine cultures are mandatory before starting therapy and after completion to confirm microbial clearance.
Genito-urinary infections acquired through sexual contact require specific antimicrobial regimens that often target dual infections simultaneously, such as gonorrhea and chlamydia.
Antimicrobial resistance is a growing public health crisis across Nigeria, heavily impacting the management of genito-urinary disorders. Over-the-counter availability of potent antibiotics, incomplete patient courses, and empirical prescribing without laboratory support drive this trend.
Pathogens like Escherichia coli frequently display resistance to older, affordable agents such as ampicillin, tetracycline, and cotrimoxazole. Extended-spectrum beta-lactamase producing organisms are increasingly isolated, leaving healthcare providers reliant on more expensive or restricted reserve antimicrobials. Understanding local antibiograms helps clinicians choose effective drugs and preserves remaining treatment options.
Nurses play a vital role in the safe administration of genito-urinary anti-infectives, monitoring for adverse reactions, and educating patients to promote adherence.
Before administering any antimicrobial, nurses must check for known drug allergies and verify baseline renal function tests, as many agents are cleared through the kidneys. Patients must understand the importance of completing the full prescribed course of antibiotics, even after urinary symptoms disappear. Stopping treatment early allows surviving resistant bacteria to multiply, leading to rapid recurrence and contributing to community-wide resistance.